Literature DB >> 7092631

Helium ion therapy for choroidal melanoma.

D H Char, J R Castro.   

Abstract

Forty patients with choroidal melanomas received radiation therapy with helium ion-charged particles. Thirty-six of 30 patients either remained stable or demonstrated tumor shrinkage. Seventeen of 18 patients followed up for at least one year after therapy demonstrated tumor regression, with a mean tumor shrinkage of approximately 40%. The most effective method of choroidal melanoma management is unclear. Charged-particle external-beam irradiation may be more applicable and have less ocular morbidity than either radioactive plaques or photocoagulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092631     DOI: 10.1001/archopht.1982.01030030943008

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Experimental study on the fractionation schedule for proton irradiation of uveal melanoma.

Authors:  G Wollensak; L Zografos; C Perret; E Egger; H Fritz-Niggli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Radiotherapy in ophthalmology : 2004 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Leonidas Zografos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-07       Impact factor: 3.117

3.  Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma.

Authors:  J C Hill; R Sealy; D Shackleton; C Stannard; J Korrubel; E Hering; C Loxton
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

4.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

5.  Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.

Authors:  P Summanen; I Immonen; T Kivelä; P Tommila; J Heikkonen; A Tarkkanen
Journal:  Br J Ophthalmol       Date:  1996-08       Impact factor: 4.638

6.  Preliminary results of proton beam irradiation of macular and paramacular melanomas.

Authors:  E S Gragoudas; M Goitein; J Seddon; L Verhey; J Munzenrider; M Urie; H D Suit; P Blitzer; K N Johnson; A Koehler
Journal:  Br J Ophthalmol       Date:  1984-07       Impact factor: 4.638

7.  Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.

Authors:  H Klaus; P K Lommatzsch; U Fuchs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

8.  Phototherapy of posterior uveal melanomas.

Authors:  I Favilla; W R Barry; A Gosbell; P Ellims; F Burgess
Journal:  Br J Ophthalmol       Date:  1991-12       Impact factor: 4.638

9.  Echographic findings in uveal melanomas treated with the Leksell gamma knife.

Authors:  K Müllner; G Langmann; G Pendl; J Faulborn
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.